Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Myasthenia Gravis ll: Pathophysiology

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Robot-Assisted Diaphragmatic Plication in an Adult Bochdalek Hernia With Intrathoracic Hepatic Displacement.

Annals of thoracic surgery short reports·2026

Same author

Neoantigen-based dendritic cell vaccines in lung cancer: overcoming immunosuppressive barriers for durable antitumor immunity.

Cancer treatment reviews·2026

Same author

Unlocking patient insights: a prospective study on patient reported outcome measures in thoracic surgery.

Journal of cardiothoracic surgery·2026

Same author

Disseminated Nocardia ignorata Infection with Splenic and Brain Involvement in Patient with Large B-Cell Lymphoma.

Emerging infectious diseases·2026

Same author

PIONEER REAL Saudi Arabia: A multicentre, prospective, real-world study of once-daily oral semaglutide use in adults with type 2 diabetes in Saudi Arabia.

Diabetes, obesity & metabolism·2025

Same author

Patient-Surgeon Communication in Thoracic Surgery: Insights from a European Multi-Country Survey on the Perioperative Experience.

Interdisciplinary cardiovascular and thoracic surgery·2025

Search research articles

Related Experiment Video

Updated: Apr 30, 2026

Robotic Myotomy and Partial Fundoplication for Achalasia

Robotic Myotomy and Partial Fundoplication for Achalasia

Published on: August 11, 2023

Robotic thymectomy for myasthenia gravis.

Mahmoud Ismail¹, Marc Swierzy¹, Ralph I Rückert²

¹Bereich Thoraxchirurgie, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.

Thoracic Surgery Clinics

|May 1, 2014

Summary

Robotic thymectomy using the da Vinci system offers a new approach for thymic gland surgery. This technique is suitable for myasthenia gravis patients with specific antibody profiles and early-stage thymoma.

Keywords:

Myasthenia gravis Robotic thymectomy Thymoma

More Related Videos

Author Spotlight: Cutting-Edge Robotic Heller Myotomy Protocol for Treatment of Achalasia

Author Spotlight: Cutting-Edge Robotic Heller Myotomy Protocol for Treatment of Achalasia

Published on: February 16, 2024

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome

Published on: January 23, 2026

Related Experiment Videos

Last Updated: Apr 30, 2026

Robotic Myotomy and Partial Fundoplication for Achalasia

Robotic Myotomy and Partial Fundoplication for Achalasia

Published on: August 11, 2023

Author Spotlight: Cutting-Edge Robotic Heller Myotomy Protocol for Treatment of Achalasia

Author Spotlight: Cutting-Edge Robotic Heller Myotomy Protocol for Treatment of Achalasia

Published on: February 16, 2024

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome

Published on: January 23, 2026

Area of Science:

Thoracic surgery
Minimally invasive surgical techniques
Neuromuscular disease treatment

Background:

Thymectomy is a key treatment for myasthenia gravis.
Robotic surgery represents an advancement in thoracic procedures.
Patient selection is crucial for optimal thymectomy outcomes.

Purpose of the Study:

To describe the application of robotic thymectomy for myasthenia gravis.
To outline patient selection criteria for this robotic approach.
To detail the indications for robotic-assisted thymectomy in thymoma.

Main Methods:

Utilizing the da Vinci robotic system for thymectomy.
Performing robotic thymectomy in patients with myasthenia gravis.
Indicating robotic surgery for resectable thymoma (Masaoka-Koga stages I-II).

Main Results:

Robotic thymectomy is the latest development in thymic gland surgery.
The procedure is indicated for specific patient groups with myasthenia gravis.
Robotic approach is suitable for early-stage thymoma.

Conclusions:

Robotic thymectomy is a viable option for select myasthenia gravis patients.
The da Vinci system facilitates advanced thymic gland surgery.
This technique is particularly relevant for early-stage thymoma management.